Cholinergic neuronal modulations affect striatal dopamine transporter activity: PET studies in the conscious monkey brain.
Tsukada
H
H
Central Research Laboratory, Hamamatsu Photonics K. K., Shizuoka 434-8601, Japan. tsukada@crl.hpk.co.jp
Nishiyama
S
S
Ohba
H
H
Sato
K
K
Harada
N
N
Kakiuchi
T
T
D000818:Animals; D002799:Cholinergic Fibers / Q000187:drug effects / Q000378:metabolism*; D003243:Consciousness; D003342:Corpus Striatum / Q000166:cytology / Q000000981:diagnostic imaging / Q000378:metabolism*; D050483:Dopamine Plasma Membrane Transport Proteins; D008253:Macaca mulatta; D008297:Male; D008464:Mecamylamine / Q000494:pharmacology; D008562:Membrane Glycoproteins; D026901:Membrane Transport Proteins / Q000378:metabolism*; D018727:Muscarinic Antagonists / Q000494:pharmacology*; D009419:Nerve Tissue Proteins; D018733:Nicotinic Antagonists / Q000494:pharmacology; D012601:Scopolamine / Q000494:pharmacology*; D014055:Tomography, Emission-Computed
D050483:Dopamine Plasma Membrane Transport Proteins; D008562:Membrane Glycoproteins; D026901:Membrane Transport Proteins; D018727:Muscarinic Antagonists; D009419:Nerve Tissue Proteins; D018733:Nicotinic Antagonists; D008464:Mecamylamine; D012601:Scopolamine